← Back
Data updated: Mar 10, 2026
TANVEX BIOPHARMA USA INC
Oncology
TANVEX BIOPHARMA USA INC is a biotechnology company focused on Oncology.
2024
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 2
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-06-28
- Latest
- 2024-06-28
- Applications
- 1